(RHM) Rheinmetall - Ratings and Ratios
Combat Vehicles, Ammunition, Sensors, Hydrogen, Actuators
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.53% |
| Yield on Cost 5y | 10.36% |
| Yield CAGR 5y | 4.39% |
| Payout Consistency | 87.3% |
| Payout Ratio | 41.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 39.2% |
| Value at Risk 5%th | 61.1% |
| Relative Tail Risk | -5.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.00 |
| Alpha | 147.33 |
| CAGR/Max DD | 3.52 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.409 |
| Beta | -0.151 |
| Beta Downside | -0.334 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.43% |
| Mean DD | 5.89% |
| Median DD | 4.98% |
Description: RHM Rheinmetall December 03, 2025
Rheinmetall AG (XETRA:RHM) is a German-based supplier of mobility and security technologies, operating globally across five segments: Vehicle Systems (armored and logistics vehicles, CBRN protection, artillery), Weapon & Ammunition (firearms, propellants, protection systems), Electronic Solutions (sensors, networking, cyber-defense, training simulators), Power Systems (e-mobility, hydrogen, thermal management, bearings) and assorted aftermarket services.
In FY 2023 the group generated €6.5 bn of revenue, with the Vehicle Systems and Weapon & Ammunition divisions contributing roughly 55 % of sales. The order backlog stood at about €3 bn, reflecting heightened European defense budgets (average 4 % YoY increase in 2023) and growing demand for digital battlefield solutions. R&D intensity remains near 6 % of revenue, supporting its push into autonomous and hydrogen-powered platforms.
Given the sector’s exposure to sovereign defense spending cycles and the company’s diversified product mix, analysts watch both the German-US defense spending outlook and the pace of e-mobility adoption as key drivers of future earnings. For a deeper dive into RHM’s valuation metrics and scenario analysis, check the ValueRay research hub.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (841.0m TTM) > 0 and > 6% of Revenue (6% = 659.9m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -6.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.04% (prev 17.19%; Δ -7.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 719.0m <= Net Income 841.0m (YES >=105%, WARN >=100%) |
| Net Debt (1.24b) to EBITDA (1.52b) ratio: 0.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (45.9m) change vs 12m ago 3.66% (target <= -2.0% for YES) |
| Gross Margin 52.12% (prev 29.98%; Δ 22.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 78.16% (prev 70.70%; Δ 7.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.97 (EBITDA TTM 1.52b / Interest Expense TTM 129.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.42
| (A) 0.07 = (Total Current Assets 9.28b - Total Current Liabilities 8.17b) / Total Assets 15.66b |
| (B) 0.29 = Retained Earnings (Balance) 4.59b / Total Assets 15.66b |
| (C) 0.08 = EBIT TTM 1.16b / Avg Total Assets 14.07b |
| (D) 0.43 = Book Value of Equity 4.71b / Total Liabilities 10.99b |
| Total Rating: 2.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.68
| 1. Piotroski 6.0pt |
| 2. FCF Yield 0.13% |
| 3. FCF Margin 0.89% |
| 4. Debt/Equity 0.52 |
| 5. Debt/Ebitda 0.81 |
| 6. ROIC - WACC (= 11.18)% |
| 7. RoE 19.06% |
| 8. Rev. Trend 73.81% |
| 9. EPS Trend 27.89% |
What is the price of RHM shares?
Over the past week, the price has changed by -5.16%, over one month by -11.38%, over three months by -19.14% and over the past year by +150.45%.
Is RHM a buy, sell or hold?
What are the forecasts/targets for the RHM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2203.9 | 44.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2668.7 | 74.8% |
RHM Fundamental Data Overview December 11, 2025
Market Cap EUR = 73.25b (73.25b EUR * 1.0 EUR.EUR)
P/E Trailing = 87.2674
P/E Forward = 39.6825
P/S = 6.6602
P/B = 14.6086
P/EG = 0.9139
Beta = 0.395
Revenue TTM = 11.00b EUR
EBIT TTM = 1.16b EUR
EBITDA TTM = 1.52b EUR
Long Term Debt = 1.20b EUR (from longTermDebt, last quarter)
Short Term Debt = 552.0m EUR (from shortTermDebt, last fiscal year)
Debt = 2.42b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 1.24b EUR (from netDebt column, last fiscal year)
Enterprise Value = 75.12b EUR (73.25b + Debt 2.42b - CCE 557.0m)
Interest Coverage Ratio = 8.97 (Ebit TTM 1.16b / Interest Expense TTM 129.0m)
FCF Yield = 0.13% (FCF TTM 98.0m / Enterprise Value 75.12b)
FCF Margin = 0.89% (FCF TTM 98.0m / Revenue TTM 11.00b)
Net Margin = 7.65% (Net Income TTM 841.0m / Revenue TTM 11.00b)
Gross Margin = 52.12% ((Revenue TTM 11.00b - Cost of Revenue TTM 5.27b) / Revenue TTM)
Gross Margin QoQ = 50.76% (prev 53.42%)
Tobins Q-Ratio = 4.80 (Enterprise Value 75.12b / Total Assets 15.66b)
Interest Expense / Debt = 1.11% (Interest Expense 27.0m / Debt 2.42b)
Taxrate = 29.66% (86.0m / 290.0m)
NOPAT = 813.9m (EBIT 1.16b * (1 - 29.66%))
Current Ratio = 1.14 (Total Current Assets 9.28b / Total Current Liabilities 8.17b)
Debt / Equity = 0.52 (Debt 2.42b / totalStockholderEquity, last quarter 4.67b)
Debt / EBITDA = 0.81 (Net Debt 1.24b / EBITDA 1.52b)
Debt / FCF = 12.64 (Net Debt 1.24b / FCF TTM 98.0m)
Total Stockholder Equity = 4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.37% (Net Income 841.0m / Total Assets 15.66b)
RoE = 19.06% (Net Income TTM 841.0m / Total Stockholder Equity 4.41b)
RoCE = 20.62% (EBIT 1.16b / Capital Employed (Equity 4.41b + L.T.Debt 1.20b))
RoIC = 16.49% (NOPAT 813.9m / Invested Capital 4.94b)
WACC = 5.31% (E(73.25b)/V(75.67b) * Re(5.46%) + D(2.42b)/V(75.67b) * Rd(1.11%) * (1-Tc(0.30)))
Discount Rate = 5.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF Debug] Terminal Value 79.01% ; FCFE base≈411.2m ; Y1≈432.4m ; Y5≈507.3m
Fair Price DCF = 199.3 (DCF Value 8.89b / Shares Outstanding 44.6m; 5y FCF grow 5.59% → 3.0% )
EPS Correlation: 27.89 | EPS CAGR: -8.53% | SUE: -1.21 | # QB: 0
Revenue Correlation: 73.81 | Revenue CAGR: 12.01% | SUE: -0.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=4.29 | Chg30d=+0.190 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=42.68 | Chg30d=-1.099 | Revisions Net=-5 | Growth EPS=+47.6% | Growth Revenue=+34.8%